Horizon Therapeutics Plc
(NASDAQ : HZNP)

... ...
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
HZNPHorizon Therapeutics Plc -1.99%77.345.6%$200.92m
VRXValeant Pharmaceuticals International, Inc. -1.93%25.9014.1%$152.40m
CTLTCatalent, Inc. -1.06%114.022.1%$112.46m
BHCBausch Health Cos., Inc. -1.74%25.950.0%$89.35m
JAZZJazz Pharmaceuticals Plc 0.47%166.592.4%$87.75m
UTHRUnited Therapeutics Corp. 1.61%169.9514.1%$65.80m
SAGESAGE Therapeutics, Inc. -4.62%92.297.6%$55.60m
ACSTAcasti Pharma, Inc. -4.85%0.600.2%$50.04m
GWPHGW Pharmaceuticals Plc 0.34%138.306.1%$48.56m
AMRNAmarin Corp. Plc -0.49%6.101.5%$47.26m
PRGOPerrigo Co. Plc -0.78%44.306.8%$46.97m
ISRIsoRay, Inc. 4.18%1.992.5%$45.31m
ICLRICON plc -0.62%209.354.2%$42.62m
PCRXPacira Biosciences, Inc. -1.24%76.2010.0%$37.93m
ARGXargenx SE -0.03%282.080.0%$37.76m

Company Profile

Horizon Therapeutics Plc is a biopharmaceutical company, which is engages in the research, development, and marketing of pharmaceutical products. It operates through the Orphan and Rheumatology, and Inflammation segments. The Orphan and Rheumatology segment consists of medicines KRYSTEXXA, RAVICTI, PROCYSBI, ACTIMMUNE, BUPHENYL, QUINSAIR, and RAYOS. The Inflammation segment comprises of medicines PENNSAID 2%, DUEXIS, and VIMOVO. The company was founded in 2008 and is headquartered in Dublin, Ireland.